|Bid||0.9400 x 1000|
|Ask||0.9600 x 2900|
|Day's Range||0.9350 - 0.9705|
|52 Week Range||0.6000 - 2.3300|
|Beta (3Y Monthly)||1.55|
|PE Ratio (TTM)||1.63|
|Earnings Date||Sep 20, 2017 - Sep 25, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.81|
As part of its ongoing efforts to improve the lives of children in the communities it serves, The Rite Aid Foundation is welcoming a new class of charities into its KidCents program for 2019, offering grants to nonprofits that advance the health and wellbeing of children. A total of 416 charities will receive a $5,000 KidCents grant, totaling more than $2 million.
Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CORAL GABLES, FL / ACCESSWIRE / January 8, 2019 / The healthcare industry is predicated on the notion that as diseases become more advanced and difficult to treat, companies responsible for creating treatment options will rise to the occasion to assist patients suffering from said ailments. As healthcare companies work to develop new methods for bettering the care provided to their patients, the industry, in its entirety, will unite to meet the demands and needs of consumers in the space looking for qualitative healthcare. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Rite Aid Corporation (RAD), Fred's Inc (FRED), and Teladoc Health Inc (TDOC), are 4 healthcare stocks representing companies invested in creating the best quality treatments for their patients.
HENDERSON, NV / ACCESSWIRE / January 8, 2019 / 2018 was the worst year for stocks in 10 years, this is great news for bargain hunters in 2019. Several strong companies became oversold and as the market ...
Rite Aid Corporation announced today that John Standley, chief executive officer; Kermit Crawford, president and chief operating officer; and Darren Karst, senior executive vice president, chief financial officer and chief administrative officer, will participate in the 37th Annual J.P.
Shares of the drugstore chain have fallen 64 percent over the past year, down to 75 cents per share as of Thursday's close from $2.11 on Jan. 3, 2018.
Rite Aid may be de-listed from the New York Stock Exchange. Shares of Rite Aid have fallen 64 percent over the past year, down to 75 cents per share as of Thursday's close from $2.11 on Jan. 3, 2018. Rite Aid may pursue a reverse stock split if its stock price does not increase.
Rite Aid Corporation (RAD) announced today that the New York Stock Exchange (NYSE) has notified the company that it is no longer in compliance with NYSE continued listing standard rules because the per share trading price of its common stock has fallen below the NYSE’s share price rule. The NYSE requires the average closing price of a listed company’s common stock to be at least $1.00 per share over a consecutive 30 trading-day period.
CORAL GABLES, FL / ACCESSWIRE / January 2, 2019 / As we dive, head-first into the new year, companies in the healthcare sector are working tirelessly to create and implement nuanced methods for treating patients with a myriad of diseases and ailments. From data-based care solutions to improved treatment options, Premier Health Group (OTC:PHGRF) (CSE:PHGI), Novavax Inc (NASDAQ: NVAX), Rite Aid Corporation (NYSE:RAD), and Bausch Health Companies Inc (NYSE: BHC) are 4 healthcare stocks representing companies prepared to innovate towards the future of the industry. Premier Health Group (OTC:PHGRF) (CSE:PHGI), a company dominating the telehealth sector of the healthcare industry, enjoyed a strong month of bullish trading back in December, with Company shares soaring well above the 30% mark in a 30-day period.
From data-based care solutions to improved treatment options, Premier Health Group (PHGRF) (PHGI), Rite Aid Corporation (RAD), Adamis Pharmaceuticals Corp (ADMP), and Synergy Pharmaceuticals Inc (SGYP) are 4 pharma stocks heating up on Monday. Synergy Pharmaceuticals, Inc (SGYP) a biopharmaceutical company that is largely focused on developing originative gastrointestinal therapies, announced earlier this month that it had entered into an agreement with Bausch Health Companies Inc. through which Bausch Health would acquire substantially all of Synergy's assets, including all rights to TRULANCE®,dolcanatide and related intellectual property, for approximately $200 million in cash.
CORAL GABLES, FL / ACCESSWIRE / December 28, 2018 / The healthcare industry has shown tremendous growth over the last few months, as experts and professionals in the field have worked on developing technologies to improve the quality of care for patients on a global scale. From data-based approaches and analysis consumer demands/needs, advancements in the sector may catalyze potential opportunities for those looking to healthcare. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Akers Biosciences Inc (AKER), CASI Pharmaceuticals Inc (CASI), and Rite Aid Corporation (RAD) represent 4 healthcare companies innovating towards the future. Premier Health Group (OTC:PHGRF) (CSE:PHGI) announced, earlier this month that as part of its overarching strategy to cover major verticals associated with primary care, it had signed into a binding Letter of Intent (LOI) agreement to acquire a Vancouver-based pharmacy.
Rite Aid Corporation today announced that it has entered into a new senior secured credit agreement, consisting of a $2.7 billion senior secured asset-based revolving credit facility and a $450 million “first-in, last out” senior secured term loan facility.
Walgreens earnings and sales narrowly topped fiscal first-quarter estimates. The Dow Jones component vowed "transformational" cost cuts. Walgreens stock fell.
Rite Aid's (RAD) top and bottom lines improve year over year. Also, earnings came ahead of the Zacks Consensus Estimate but sales lagged the same.
CORAL GABLES, FL / ACCESSWIRE / December 20, 2018 / The biotech industry has shown tremendous growth over the course of the last several months, as medical experts and professionals have sought to test ...
Check out the companies making headlines before the bell: Walgreens Boots Alliance WBA – Walgreens earned an adjusted $1.46 per share for its latest quarter , 3 cents a share above estimates. Revenue also came in above analysts' forecasts and the company announced plans to cut $1 billion in costs.
Rite Aid (RAD) delivered earnings and revenue surprises of 150.00% and -0.62%, respectively, for the quarter ended November 2018. Do the numbers hold clues to what lies ahead for the stock?
Rite Aid Corporation (RAD) and McKesson Corporation (MCK) announced an agreement to key terms that will continue the companies’ pharmaceutical sourcing and distribution partnership for an additional 10 years. Under these terms, McKesson will continue providing Rite Aid with sourcing and direct-to-store delivery for brand and generic pharmaceutical products through March 2029.
CAMP HILL, Pa.-- -- Third Quarter Net Loss from Continuing Operations of $17.3 Million or $0.02 Per Share, Compared to the Prior Year Third Quarter Net Loss of $18.2 Million or $0.02 Per Share Third Quarter Adjusted Net Income from Continuing Operations of $14.7 million or $0.01 Per Share, Compared to the Prior Year Third Quarter Adjusted Net Income of $8.5 Million or $0.01 Per Share Third Quarter ...